STAGE 0A BLADDER CANCER AJCC V8
Clinical trials for STAGE 0A BLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE 0A BLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE 0A BLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to fight tough bladder cancer
Disease control OngoingThis phase II trial is testing whether adding the immunotherapy drug pembrolizumab to the chemotherapy drug gemcitabine can help patients with a type of bladder cancer that does not respond to the usual BCG treatment. The study involves 161 participants and looks at how many pati…
Matched conditions: STAGE 0A BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Bladder cancer survivors share how treatment changes their daily lives
Knowledge-focused OngoingThis study follows 204 people with bladder cancer to see how their quality of life changes after treatment like surgery or radiation. Participants fill out surveys about physical function, pain, fatigue, anxiety, and bladder, bowel, and sexual health. The goal is to understand ho…
Matched conditions: STAGE 0A BLADDER CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC